Sort
10,766 grants matching “checkpoint inhibitor”
Bio-Physical Modeling of Immuno-Radiotherapy Combinations based on Patient Data
$216,282Clemens Grassberger · Massachusetts General Hospital · R21 · FY2019 · CA
Liquid Biopsy Core
$216,213Amir Goldkorn · University Of Southern California · P30 · FY2023 · CA
In situ single cell imaging
$216,126Feng Gao · Dotquant, Llc · R44 · FY2019 · CA
Role of Acid in the Development of Barrett's Esophagus
$216,090Rhonda F Souza · Ut Southwestern Medical Center · R01 · FY2008 · DK
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$216,070Temesgen Samuel · Tuskegee University · U54 · FY2023 · CA
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$216,070Temesgen Samuel · Tuskegee University · U54 · FY2022 · CA
Targeting USP10 to regulate the DNA damage response in NSCLC
$215,985Xiaohong Mary Zhang · Wayne State University · R21 · FY2021 · CA
Exosome Signatures of Kidney Cancer Response to Immune Checkpoint Inhibitor
$215,985Alice Chen Fan · Stanford University · R21 · FY2025 · CA
Quantitative evaluation of focused ultrasound thermal therapy on immunogenic cell death in breast cancer
$215,985Allison Payne · Utah State Higher Education System--University Of Utah · R21 · FY2025 · CA
Liposome-based mRNA cancer immunotherapy targeting ion channels
$215,846Laura Conforti · University Of Cincinnati · R21 · FY2024 · CA
Mitotic Catastrophe in Tumor Cells
$215,630Ordway Research Institute, Inc. · R01 · FY2003 · CA
Mechanisms of resistance to immune therapy in NSCLC
$215,604Qingsheng Li · University Of Louisville · P20 · FY2024 · GM
Cell-Free Nucleic Acids for Early Treatment Response Assessment of Hepatocellular Cancer
$215,495Aadel Chaudhuri · Washington University · K08 · FY2020 · CA
Hormone Control of Cell Proliferation and Differentiation
$215,453Virginia Rider · Pittsburg State University · · FY2001 · BIO
Bispecific drug-conjugates for treating colorectal cancer
$215,308Kendra S. Carmon · University Of Texas Hlth Sci Ctr Houston · R21 · FY2025 · CA
CONTROL OF INITIATION OF DNA REPLICATION IN LUNG CANCER
$215,160Edward M. Johnson · Eastern Virginia Medical School · R01 · FY2006 · CA
Investigating the Role of PFKFB4 in the Immune Regulation of Lung Cancer
$215,101Sucheta Telang · University Of Louisville · R21 · FY2023 · CA
Cell-Free Nucleic Acids for Early Treatment Response Assessment of Hepatocellular Cancer
$214,949Aadel Chaudhuri · Washington University · K08 · FY2021 · CA
Engineering Siglec15/TGF-beta targeted bispecific antibodies that modulate the tumor microenvironment and enhances T-cell immunotherapy against pancreatic cancer
$214,931Samuel Lai · Univ Of North Carolina Chapel Hill · R21 · FY2023 · CA
Anti-tumor efficacy of novel cGAS-STING pathway agonists
$214,767Victor Robert Defilippis · Oregon Health & Science University · R21 · FY2022 · CA
Mechanisms of Th17-DC immunotherapy for ovarian cancer
$214,583Martin J Cannon · Univ Of Arkansas For Med Scis · R21 · FY2024 · CA
SR-A as a therapeutic target in breast cancer
$214,583Post Steven · Univ Of Arkansas For Med Scis · R21 · FY2024 · CA
Development of pHLIP-phosphoantigen conjugates for lymphoma therapy
$214,513Andrew J Wiemer · University Of Connecticut Storrs · R21 · FY2024 · CA
Understanding PD-L1/L2 protein regulation, detection and signaling to predict melanoma therapeutic sensitivity
$214,414Roger S Lo · University Of California Los Angeles · R21 · FY2022 · CA
Structural Determinants in Cell Growth Control by p21 and p27
$214,402Richard W Kriwacki · St. Jude Children'S Research Hospital · R01 · FY2008 · CA